Ofloglee 400 Tablet contains Ofloxacin 400mg, a powerful fluoroquinolone antibiotic for broad-spectrum bacterial infections. It works by inhibiting bacterial DNA synthesis, ensuring effective elimination of pathogens in urinary, respiratory, gastrointestinal, and skin infections.
This tablet is widely prescribed due to its high efficacy, rapid action, and safety profile, providing patients with quick relief and reduced risk of infection recurrence. Its reliability makes it a preferred choice among physicians for common and complicated bacterial infections.
For franchise partners, Ofloglee 400 Tablet is a high-demand product in the antibiotic segment, offering strong prescriber confidence and consistent repeat orders. Its clinical relevance ensures profitable growth and enhanced market presence in anti-infective therapy.
With increasing incidences of bacterial infections, Ofloglee 400 Tablet provides sustainable business opportunities, helping partners strengthen their portfolio in the antibiotic and infection control segment.